ASX Announcements

Every company announcement lodged with the ASX — browse the selected trading day or search the historical archive.

RCERECCE PHARMACEUTICALS LTD

Search keywords from ASX announcement titles across the ASX announcement archive.

All dates

RECCE PHARMACEUTICALS LTD (ASX: RCE)

63 announcements

Date / TimeTitleType
19 Aug 2026, 21:02HREC Approves Comparator Study for Pivotal Phase 3 DFICompany Update
7 Aug 2026, 02:55Change of Director's Interest Notices (x4)Director Interests
5 Aug 2026, 02:12Cleansing NoticeSecurities Administration
3 Aug 2026, 18:23Application for quotation of securities - RCEOther
31 July 2026, 21:32Completion of Share Purchase Plan and Shortfall NoticeCapital Raising
31 July 2026, 21:30Application for quotation of securities - RCEOther
31 July 2026, 19:04Notice of General Meeting/Proxy FormMeetings & Governance
30 July 2026, 20:38U.S. Government Releases US$66.9B AMR Biodefense StrategyCompany Update
21 July 2026, 22:50Investor Webinar - Q4 FY26 Investor Presentation DeckPresentations
21 July 2026, 22:27Investor Webinar - 2.30PM (AEST) 21 July 2026Presentations
21 July 2026, 22:20Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
20 July 2026, 19:33Update - Proposed issue of securities - RCESecurities Administration
20 July 2026, 19:29Extension to Share Purchase Plan Closing DateCapital Raising
14 July 2026, 18:56Vietnamese Patent Granted for RECCE Anti-InfectivesCompany Update
6 July 2026, 19:06Share Purchase Plan - Letter and Offer BookletCapital Raising
4 July 2026, 00:31Cleansing NoticeSecurities Administration
4 July 2026, 00:25Application for quotation of securities - RCEOther
3 July 2026, 02:26Notification of cessation of securities - RCEOther
1 July 2026, 21:30Cleansing NoticeSecurities Administration
1 July 2026, 21:24Application for quotation of securities - RCEOther
1 July 2026, 21:10Application for quotation of securities - RCEOther
1 July 2026, 21:04Application for quotation of securities - RCEOther
1 July 2026, 19:07AUD $3.7M Income Tax Refund ReceivedCompany Update
27 June 2026, 04:00Proposed issue of securities - RCESecurities Administration
26 June 2026, 20:35RCE Investor PresentationPresentations
26 June 2026, 20:19Proposed issue of securities - RCESecurities Administration
26 June 2026, 20:03Placement & SPP to raise $8 millionCapital Raising
24 June 2026, 20:08Trading HaltTrading Halt / Suspension
24 June 2026, 19:54Pause in TradingTrading Halt / Suspension
22 June 2026, 20:03HREC Approval Accelerates Global Phase 3 DFI StrategyCompany Update
27 May 2026, 23:49Addendum to Recce Signs Middle East Licensing Term SheetCompany Update
27 May 2026, 19:48Recce Signs Middle East Licensing Term SheetCompany Update
1 May 2026, 03:03Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
21 Apr 2026, 20:52Positive Regulatory Inspection Outcome for Phase 3 TrialCompany Update
16 Apr 2026, 03:28Notification of cessation of securities - RCEOther
24 Mar 2026, 22:52Brazil Patent Granted for RECCE Anti-InfectivesCompany Update
19 Mar 2026, 21:43RCE Investor Webinar Presentation DeckPresentations
18 Mar 2026, 02:00RCE Investor Webinar PresentationPresentations
28 Feb 2026, 05:02Appendix 4D and Interim Financial ReportFinancial Results
25 Feb 2026, 04:51Change of Director's Interest Notices (x5)Director Interests
25 Feb 2026, 04:17Notification of cessation of securities - RCEOther
2 Feb 2026, 19:58Recce Enters Second U.S. Department of Defense R&D AgreementCompany Update
31 Jan 2026, 00:01Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
14 Jan 2026, 21:37AUD $5.3m R&D Rebate ReceivedPeriodic Reports
16 Dec 2025, 20:48RCE Awarded Advanced Overseas Finding up to A$85mPeriodic Reports
27 Nov 2025, 21:05Hong Kong Patent Granted for RECCE Anti-InfectivesCompany Update
26 Nov 2025, 20:50Positive Efficacy Data for Inhaled R327 in HAP/VAP ModelCompany Update
15 Nov 2025, 03:08Passing of Dr Graham Melrose - Recce founder and inventorCompany Administration
6 Nov 2025, 01:09Results of MeetingMeetings & Governance
5 Nov 2025, 19:58AGM PresentationPresentations
1–50 of 63
1 / 2

Bold Investors provides factual coverage of ASX company announcements and is not affiliated with, or endorsed by, ASX Limited. Nothing on this page is financial advice.